Delivery Order SPE2DR25D3012-SPE2DR26F4B9P
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $1,941.48 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This firm fixed-price, non-set-aside contract is scheduled for completion by November 13, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,946.92, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 14, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,235.90 to AmerisourceBergen Drug Corp for OxyContin ER 15 mg tablets (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,241.90 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 10 mg tablets (100-count packages). The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 15 mg tablets (100-count units) valued at $1,926.09 under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order as a child contract under its larger indefinite delivery...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4B9PDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,867.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for OxyContin ER 15 mg tablets in quantities of 100. The award is a non-set-aside competitive delivery order with an ultimate completion date of November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitive procurement processes, with previous awards ranging from minimal value to substantial orders exceeding $45,000. This award supports DLA's medical supply chain requirements and reflects AmerisourceBergen's role as a primary pharmaceutical provider within the Department of Defense's healthcare logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/18/25 |